Ngā hua rapu - Nicola Papapietro
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
-
2
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw mā Bruno Vincenzi, Andrea Napolitano, Alice Zoccoli, Michele Iuliani, Francesco Pantano, Nicola Papapietro, Vincenzo Denaro, Daniele Santini, Giuseppe Tonini
I whakaputaina 2012Carta -
3
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions mā Marco Fioramonti, Daniele Santini, Michele Iuliani, Giulia Ribelli, Paolo Manca, Nicola Papapietro, Filippo Spiezia, Bruno Vincenzi, Vincenzo Denaro, Antonio Russo, Giuseppe Tonini, Francesco Pantano
I whakaputaina 2017Artigo -
4
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases mā Daniele Santini, Giuseppe Perrone, Ilaria Roato, Laura Godio, Francesco Pantano, Donatella Grasso, Antonio Russo, Bruno Vincenzi, Maria Elisabetta Fratto, Roberto Sabbatini, Chiara Della Pepa, Camillo Porta, Alessandro Del Conte, Gaia Schiavon, Alfredo Berruti, Rosa Maria Tomasino, Mauro Papotti, Nicola Papapietro, Andrea Onetti Muda, Vincenzo Denaro, Giuseppe Tonini
I whakaputaina 2010Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Cancer
Internal medicine
Pathology
Activator (genetics)
Cancer research
Oncology
Osteoprotegerin
RANKL
Receptor
Angiogenesis
Biochemistry
Bioinformatics
Biology
Bisphosphonate
Bisphosphonate-associated osteonecrosis of the jaw
Bone metastasis
Bone remodeling
Cabozantinib
Chemistry
Conservative management
Degeneration (medical)
Discectomy
Gastroenterology
Hematology
Immunohistochemistry
In vitro
Intervertebral disc
Lumbar
Mesenchymal stem cell